ComfortInStocks

Millennial in UK growing wealth by dipping into stocks % bonds with a Cash Free ISA. On a journey to financial comfort. do your own research and due dilligence.

[Kromek Group plc @kromekgroup]

Kromek are delighted to announce our partnership with Siegrist GmbH, who are now the official distributors of Kromek products in Germany.

Read the full news story here: https://t.co/ZwEbkj72zu

#kromek #kmk #siegrist #cbrn #partnership

[ComfortInStocks @ComfortInStocks]

Wow!!!

[Kromek Group plc @kromekgroup]

Kromek has successfully built a highly-specialised bioaerosol evaluation chamber at its headquarters in Sedgefield, County Durham, making it one of very few facilities of its kind, currently operating in the UK.

https://t.co/N58QFCJ09i

#bioaerosol #virus #detection #kromek #kmk

[ComfortInStocks @ComfortInStocks]

@Ashton_1nvests $IMUX

[ComfortInStocks @ComfortInStocks]

@SimeonResearch_ @Ashton_1nvests I have concentrated down now and will do so for a few years as I grow my ETFS. I have $GRWG $KMK $IMUX and $80M (80 Mile ))

[ComfortInStocks @ComfortInStocks]

@ToffCap I just use $FRIN for a long Indian economy play on the route to 2047 ( 100 years of independence)

[Immunic Therapeutics @ImmunicInc]

💡 From Lifeguard to C-Suite: #Leadership Lessons from #Immunic's President & COO, Jason Tardio 🎓

What does it really take to lead in executive functions? In this interview with @AuthorityMgzine, Jason shares key insights and his personal "𝟱 𝗧𝗵𝗶𝗻𝗴𝘀 𝗜 𝗪𝗶𝘀𝗵 𝗦𝗼𝗺𝗲𝗼𝗻𝗲 𝗧𝗼𝗹𝗱 𝗠𝗲 𝗕𝗲𝗳𝗼𝗿𝗲 𝗜 𝗕𝗲𝗴𝗮𝗻 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗙𝗿𝗼𝗺 𝘁𝗵𝗲 𝗖-𝗦𝘂𝗶𝘁𝗲."

📖 Full interview: https://t.co/Wgte2trSib

$IMUX #management #healthcare #biotech #pharma

[Kromek Group plc @kromekgroup]

What have the Kromek team been up to? 🤔

Hear all about the team's May adventures in next week's edition of Kromek's Company Newsletter.

Subscribe today:
https://t.co/6HyKex8c3l

#kromek #kmk #cbrn #newsletter

[Proactive @proactive_x]

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial Enrollment @ImmunicInc #NASDAQ #IMUX https://t.co/FhXyCO6vHx

[ComfortInStocks @ComfortInStocks]

@teezyweezy1919 It's a long ride. Newly listed, most firms make or break after 10 years as a listed entity. Soooo much could happen in the 7 or so.

[ComfortInStocks @ComfortInStocks]

@lindros8887 @ImmunicInc It has stung a bit! Lost 50% of my holding with this announcement but I'm still riding it out long term. Going to be a painful one to DCA over the next 12 months.

[ComfortInStocks @ComfortInStocks]

@DavidBurton1971 @metals_one_plc @80milePLC I've watched and been "in" 80M for over a year and their relationship with the Greenland government is fantastic...which is important. Seems like they are good at getting outsider capital for projects too.

[Kromek Group plc @kromekgroup]

Check out our newsletter archive to catch-up on the latest in CBRN detection and sign-up to make sure you don't miss another!

https://t.co/HZt3jJZZuz

#kromek #kmk #newsletter

[ComfortInStocks @ComfortInStocks]

@investwithwes1 Mine too, wish I had a £100 or more to stick jnto a few single stocks. My ETFs are long but swinging the stocks is hard right now!

[ComfortInStocks @ComfortInStocks]

@amktparticipant I think it's a wise move, single firm stocks that rely on retail income is risky anyway. I avoid retail based companies (apart from $NESN ) because currently, and for the next decade...99% of goods are luxury. People can't spend 100s on exercise items or flashy cars etc anymore.

[Wesley Chambers @investwithwes1]

My favourite quote when it comes to thinking about declining market

[Ian Cassel @iancassel]

Often times your best investment opportunities are already in the portfolio - you always have at least one in the portfolio executing well but the stock isn't reflecting it yet. You've already did the work and trust them. No reason to add a new player when adding one isn't productive. No reason to add a .250 hitter to a lineup of .300 hitters. No reason to dilute your returns.

[ComfortInStocks @ComfortInStocks]

@ToffCap This is still stagnant but I'm building a very small position. They've managed to win a few contracts but only time will tell especially in global climates of poor employment opportunities. Got into this from your Monday report.

[ComfortInStocks @ComfortInStocks]

@investwithwes1 @filiembustero Ouch it's having real hard year or so!!

[stock setter @MarcJacksonLA]

$IMUX
-William Blair initiates Immunic coverage at Outperform, sees stock outperforming on RMS therapy

https://t.co/cmD92SjHkF

[Immunic Therapeutics @ImmunicInc]

💊 At the recent 7th Neuroimmunology Drug Development Summit, #Immunic’s CSO, Dr. Hella Kohlhof, shared insights on $IMUX's first-in-class, dual mechanism approach to #MultipleSclerosis treatment. She explored how our lead asset aims to combine #neuroprotection and relapse prevention to potentially deliver a full-spectrum impact on #MS.

💡 Get all the details here: https://t.co/98ThkY0JxP

#neurology @HansonWade